🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Status
Completed
Location
Umeyama Clinic ( Site 6406)
Start Date
2020-11-30
Trial ID
NCT04635423
This phase II trial studies how well atezolizumab and bevacizumab work in t...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-03-03
Trial ID
NCT03074513
Treatments Being Tested
This intervention study will use parent-, provider-, and health center-leve...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2023-01-09
Trial ID
NCT05677360
Treatments Being Tested
Human papillomavirus (HPV) assays are likely to be used in cervical cancer ...
Status
Unknown
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01316120
The aim of this study is to identify HPV molecular signature in head and ne...
Status
Completed
Location
Hôpital Européen Georges Pompidou
Start Date
2019-06-01
Trial ID
NCT04189003
A research project is currently being undertaken looking at Human Papilloma...
Status
Completed
Location
Royal Childrens Hospital
Start Date
2008-03
Trial ID
NCT00964210
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-12
Trial ID
NCT00552279
Treatments Being Tested
This open-label study evaluates safety, vector shedding, and retreatment ef...
Status
Recruiting
Location
Winship Cancer Institute, Emory University
Start Date
2024-07-11
Trial ID
NCT06538480
Treatments Being Tested
Objective To assess the efficacy of the topical application of Nitric Oxide...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT02015260
Treatments Being Tested
High risk human papillomavirus (hr-HPV) persistent infection is a high risk...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2023-03-01
Trial ID
NCT06467942
Treatments Being Tested